We carried out Transwell assays to evaluate the migration ability of miR-148a and PDK1 in the breast cancer cells, and showed that PDK1 counteracted the inhibitory effect of miR-148a on cell migration ability (Figure 7F). This evidence concerns the gene PDK1 and breast carcinoma.